Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction.

Source:http://linkedlifedata.com/resource/pubmed/id/11208898

Download in:

View as

General Info

PMID
11208898